Rapid, long-term labeling of cells in the developing and adult rodent visual cortex using double-stranded adeno-associated viral vectors

Developmental Neurobiology

Volumn 69, Issue 10, 2009, Pages 674-688

  Lowery, Rebecca L ^a   Zhang, Yu ^a   Kelly, Emily A ^a   Lamantia, Cassandra E ^a   Harvey, Brandon K ^b   Majewska, Ania K ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

AAV; GFP; Imaging; Labeling; Visual cortex

Indexed keywords

DOUBLE STRANDED PARVOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL LABELING; CONTROLLED STUDY; GENETIC TRANSDUCTION; IMAGING SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VISUAL CORTEX;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELL SURVIVAL; DEPENDOVIRUS; DERMOSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROINJECTIONS; MICROSCOPY, CONFOCAL; NEURONS; PATCH-CLAMP TECHNIQUES; STAINING AND LABELING; TIME FACTORS; VISUAL CORTEX;

EID: 67651202187     PISSN: 00223034     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20735     Document Type: Article

References (38)

1. Bartlett JS, Samulski RJ, McCown TJ. 1998. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 9:1181-1186.
2. Broekman ML, Comer LA, Hyman BT, Sena-Esteves M. 2006. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 138:501-510.
3. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, et al. 2004. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10:302-317.
4. Cearley CN, Wolfe JH. 2006. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 13: 528-537.
5. Chamberlin NL, Du B, de Lacalle S, Saper CB. 1998. Recombinant adeno-associated virus vector: Use for transgene expression and anterograde tract tracing in the CNS. Brain Res 793:169-175.
6. Chen SL, Ma HI, Han JM, Tao PL, Law PY, Loh HH. 2007. dsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm. Proc Natl Acad Sci USA 104:20096-20101.
7. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, Zabner J, et al. 2000. Recombinant adenoassociated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 97:3428-3432.
8. Deisseroth K, Feng G, Majewska AK, Miesenbock G, Ting A, Schnitzer MJ. 2006. Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci 26:10380-10386.
9. Ferrari FK, Samulski T, Shenk T, Samulski RJ. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70:3227-3234.
10. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 70:520-532.
11. Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X, McCarty DM. 2003. Self-complementary adeno-associated virus serotype 2 vector: Global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 8:911-917.
12. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, Wilson JM. 2004. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 78:6381-6388.
13. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. 2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99:11854-11859.
14. Harding TC, Dickinson PJ, Roberts BN, Yendluri S, Gonzalez-Edick M, Lecouteur RA, Jooss KU. 2006. Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors. Hum Gene Ther 17:807-820.
15. Howard DB, Powers K, Wang Y, Harvey BK. 2008. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 372:24-34.
16. Jeromin A, Yuan LL, Frick A, Pfaffinger P, Johnston D. 2003. A modified Sindbis vector for prolonged gene expression in neurons. J Neurophysiol 90:2741-2745.
17. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154.
18. Kim J, Dittgen T, Nimmerjahn A, Waters J, Pawlak V, Helmchen F, Schlesinger S, et al. 2004. Sindbis vector SINrep(nsP2S726): A tool for rapid heterologous expression with attenuated cytotoxicity in neurons. J Neurosci Methods 133:81-90.
19. Klein RL, Meyer EM, Peel AL, Zolotukhin S, Meyers C, Muzyczka N, King MA. 1998. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp Neurol 150:183-194.
20. Lo WD, Qu G, Sferra TJ, Clark R, Chen R, Johnson PR. 1999. Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression. Hum Gene Ther 10:201-213.
21. Majewska A. 2007. Dynamic remodeling of dendritic spines in developmental visual plasticity. Cell Sci Rev 3:85-98.
22. Majewska A, Yiu G, Yuste R. 2000. A custom-made two-photon microscope and deconvolution system. Pflugers Arch 441:398-408.
23. Majewska AK, Newton JR, Sur M. 2006. Remodeling of synaptic structure in sensory cortical areas in vivo. J Neurosci 26:3021-3029.
24. McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ. 2003. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10:2112-2118.
25. McCarty DM, Monahan PE, Samulski RJ. 2001. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8:1248-1254.
26. McCown TJ. 2005. Adeno-associated virus (AAV) vectors in the CNS. Curr Gene Ther 5:333-338.
27. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713:99-107.
28. Paterna JC, Feldon J, Bueler H. 2004. Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol 78:6808-6817.
29. Portera-Cailliau C, Weimer RM, De Paola V, Caroni P, Svoboda K. 2005. Diverse modes of axon elaboration in the developing neocortex. PLoS Biol 3:e272.
30. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ. 2002. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76:791-801.
31. Rutledge EA, Halbert CL, Russell DW. 1998. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 72: 309-319.
32. Stettler DD, Yamahachi H, Li W, Denk W, Gilbert CD. 2006. Axons and synaptic boutons are highly dynamic in adult visual cortex. Neuron 49:877-887.
33. Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L, Wilson JM, et al. 2007. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18:195-206.
34. Tenenbaum L, Chtarto A, Lehtonen E, Velu T, Brotchi J, Levivier M. 2004. Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med 6 (Suppl 1):S212-S222.
35. Wang J, Xie J, Lu H, Chen L, Hauck B, Samulski RJ, Xiao W. 2007. Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc Natl Acad Sci USA 104:13104-13109.
36. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. 2003. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 10:2105-2111.
37. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM. 1999. Gene therapy vectors based on adeno-associated virus type 1. J Virol 73:3994-4003.
38. Xiao X, Li J, Samulski RJ. 1998. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224-2232.